Angiotensin II Promotes Progressive Activation of Fibrogenic Periostin-Lineage Cells in Lung and Kidney
Cells · 2025
DOI: 10.3390/cells14201584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Mustafa Ozdemir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pathobiology and Molecular Medicine Program, Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnat…. Hauptthemen laut MEDLINE: Angiotensin II, Kidney, Lung, Cell Adhesion Molecules. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIH.
Abstract (Originalsprache)
Angiotensin II (AngII), the primary effector of the renin-angiotensin system, is essential for maintaining blood pressure and fluid-electrolyte homeostasis. However, elevated AngII levels are a feature of disease conditions such as heart failure and chronic kidney disease, where it is associated with pathological tissue remodeling and fibrosis. AngII-mediated fibrosis has been documented in multiple organs and is characterized by fibroblast expansion, myofibroblast differentiation, and excessive extracellular matrix deposition. Periostin has recently emerged as a marker of fibroblast activation. Notably, periostin expression is highly upregulated during fibrotic remodeling in the kidney and lung, which is strongly linked with impaired organ function. While AngII-induced activation of periostin-lineage (PostnLin) cells is well established in the heart, the temporal dynamics of PostnLin activation in response to AngII infusion in the lung and kidney remain unexplored. Here, we used a Postn-MerCreMer lineage-tracing approach, combined with continuous AngII infusion over an experimental period of one week and two weeks to assess PostnLin responses in lung and kidney. Our findings reveal a progressive activation of PostnLin cells in both organs, characterized by myofibroblast phenotype, together with increased collagen deposition and macrophage infiltration. These results highlight the potential of PostnLin fibroblasts as a key effector of AngII-mediated tissue remodeling and fibrosis in the lung and kidney.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathobiology and Molecular Medicine Program, Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
- Division of Basic and Translational Science, Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
- Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
ORCID-Profile: José P Guirao-Abad, Onur Kanisicak
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIH
- American Heart Association Career Development Award
Zitieren
APA
Ozdemir, M., Guirao-Abad, J. P., Kasprovic, D. A., Jaggers, R. M., & Kanisicak, O. (2025). Angiotensin II Promotes Progressive Activation of Fibrogenic Periostin-Lineage Cells in Lung and Kidney. Cells. https://doi.org/10.3390/cells14201584
Vancouver
Ozdemir M, Guirao-Abad JP, Kasprovic DA, Jaggers RM, Kanisicak O. Angiotensin II Promotes Progressive Activation of Fibrogenic Periostin-Lineage Cells in Lung and Kidney. Cells. 2025. doi:10.3390/cells14201584
BibTeX
@article{Ozdemir2025,
author = {Ozdemir, Mustafa and Guirao-Abad, José P and Kasprovic, Daniel A and Jaggers, Robert M and Kanisicak, Onur},
title = {Angiotensin II Promotes Progressive Activation of Fibrogenic Periostin-Lineage Cells in Lung and Kidney},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14201584}
}
EUVIMED